Officials have yet to keep their promise to disclose how many people are signing up during a special Obamacare enrollment season.» Read More
Sixty-three percent of Australians are overweight, a study published Thursday showed, highlighting the country's growing obesity problem.
GlaxoSmithKline salespeople in China say the company won't reimburse them for bribes they were ordered to pay out of pocket. FT reports.
Canadian drugmaker Valeant Pharmaceuticals International raised the cash component of its offer for Botox-maker Allergan by $10 per share.
More employees are getting hit with higher health premiums and co-payments, and many can't cover unexpected medical expenses. USA Today reports.
Swiss food group Nestle stepped up its drive into the fast-growing skincare market on Wednesday.
Shares of WellCare Health Plans and Centene surged Tuesday on speculation that one of the two Medicaid insurance providers could be acquired.
A MoneyRates.com survey found 33 percent of workers expect to delay their retirement because of Obamacare, and just 19 percent expect to retire early.
What's next for Pfizer, now that its bid for AstraZeneca has been laid to rest, at least temporarily. Analysts weigh in with their views.
The World Health Organization called Tuesday for a hike in tobacco taxes to encourage smokers to quit and nonsmokers from starting.
GlaxoSmithKline says Britain's Serious Fraud Office (SFO) has opened a formal criminal investigation into its commercial practices.
Could things have turned out differently? Yes, according to one source in the AstraZeneca camp who pointed to a flaw in Pfizer's strategy.
Millions of Americans each year buy prescription medication from online, international pharmacies to save money even though it's illegal.
As debate rages over costly drugs like Gilead's Solvadi, patients caution: Treatment is priceless.
Here are some apps recommendations from "Valley Girl" Jesse Draper that can help you manage your health.
Many people who previously spent lots of money for prescriptions will be helped by Obamacare, but some may be surprised at what they still owe.
The mounting scrutiny of prescription drug prices in the U.S. reached fever pitch with total spending last year rising 3.2 percent, to $329.2 billion.
U.S. pharmaceutical giant releases statement confirming that it would not be making a further multibillion-dollar offer for its U.K. rival.
Express Scripts' Steve Miller has embarked on a drug pricing crusade, with the goal of bringing down costs.
People are more stressed out at home than they are at work, new research shows, but that may be because they are trying to juggle so much.
New research from the Consumer Financial Protection Bureau concludes that medical bills are unfairly lowering credit scores.
Get the best of CNBC in your inbox